Equities

Shanghai Runda Medical Technology Co Ltd

  • Add to watchlist
  • Add to portfolio
  • Add an alert

Shanghai Runda Medical Technology Co Ltd

Actions
Health CareMedical Equipment and Services
  • Price (CNY)16.39
  • Today's Change0.20 / 1.24%
  • Shares traded20.27m
  • 1 Year change-19.70%
  • Beta0.9000
Data delayed at least 15 minutes, as of Feb 12 2026.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Shanghai Runda Medical Technology Co Ltd is a China-based company primarily engaged in the research, development, production and sales of medical devices and in vitro diagnostic reagents. The Company operates two businesses. The integrated services business provides a full-industry supply chain service to various medical laboratories, including product portfolio services, cold chain warehousing and logistics, regular instrument maintenance and repair, and localized rapid response repair services, integrated service and regional testing center service, as well as third-party laboratory testing services. The industrial business is primarily engaged in the research, development, production and manufacturing of in vitro diagnostic (IVD) products, as well as the development of digital information systems and software. The Company primarily operates its businesses in the domestic market.

  • Revenue in CNY (TTM)7.40bn
  • Net income in CNY-157.84m
  • Incorporated1999
  • Employees3.14k
  • Location
    Shanghai Runda Medical Technology Co Ltd8F, Tower 1, Xinghui Center, No. 89Zhapu Road, Hongkou DistrictSHANGHAI 200085ChinaCHN
  • Phone+86 2 168406213
  • Fax+86 2 168406213
  • Websitehttps://www.rundamedical.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
HOB Biotech Group Corp Ltd387.48m36.43m9.10bn529.00245.4510.83--23.480.58380.58386.1713.230.39381.507.30732,482.303.707.244.418.6457.8764.539.4016.211.0714.220.080542.822.019.20-22.24-10.4334.88--
Sino Medical Sciences Technology Inc504.11m29.36m9.37bn691.00317.6510.36--18.590.07060.07061.212.170.3851.6342.71729,533.101.69-5.652.05-6.4563.9263.654.40-21.721.712.660.2102--33.641.03103.78-55.92-17.21--
Shinva Medical Instrument Co Ltd9.58bn508.92m9.39bn8.14k18.501.20--0.98070.8370.83715.7812.910.62862.204.501,177,051.003.304.126.278.9724.4625.095.245.610.8863--0.12421.150.08742.715.75-4.2914.3026.58
Shanghai Runda Medical Technology Co Ltd7.40bn-157.84m9.77bn3.14k--2.34--1.32-0.2609-0.260912.466.920.52373.681.462,360,202.00-0.55773.81-1.4910.1921.9826.78-1.065.440.97231.160.560515.85-9.133.34-79.77-29.14-4.52--
Shanghai Haohai Biological Tech Co Ltd2.52bn384.21m9.95bn2.16k28.371.91--3.951.651.6510.8324.490.35121.537.841,169,728.004.944.585.965.2669.1370.3914.0714.673.24--0.065642.371.6410.951.042.55-1.8614.87
Qingdao Haier Biomedical Co Ltd2.26bn255.88m10.43bn2.81k40.462.42--4.610.81440.81447.2113.640.40084.315.12806,199.104.6810.875.9214.1245.3149.2111.6724.082.41--0.020528.140.128817.67-9.7115.03-5.5321.16
Xiangyu Medical Co Ltd773.93m73.51m10.69bn2.34k139.565.28--13.820.47890.47895.0712.670.25481.0111.40330,597.702.358.543.2610.1765.9866.789.2228.370.9871--0.238732.49-0.171711.71-54.68-4.4183.55--
Shanghai Microport EP MedTech Co Ltd458.70m52.26m11.05bn500.00211.536.17--24.100.1110.1110.97473.810.23951.336.85917,403.002.730.90842.910.957958.2464.9511.394.0910.17--0.00320.0025.5128.61815.36--35.67--
Beijing Wandong Medical Technolgy Co Ltd1.62bn14.41m11.26bn1.19k960.982.40--6.950.01670.01672.266.660.29372.732.991,360,016.000.26234.510.3045.2131.5942.820.893314.914.80--0.003943.2523.269.18-16.54-1.40-1.3921.06
Data as of Feb 12 2026. Currency figures normalised to Shanghai Runda Medical Technology Co Ltd's reporting currency: Chinese Yuan Renminbi CNY

Institutional shareholders

8.20%Per cent of shares held by top holders
HolderShares% Held
New China Asset Management Co., Ltd.as of 31 Mar 20259.63m1.66%
China Merchants Fund Management Co., Ltd.as of 30 Jun 20259.58m1.65%
China Asset Management Co., Ltd.as of 30 Jun 20255.00m0.86%
Great Wall Fund Management Co., Ltd.as of 31 Mar 20254.60m0.79%
China Southern Asset Management Co., Ltd.as of 30 Jun 20254.48m0.77%
Lion Fund Management Co., Ltd.as of 30 Jun 20254.21m0.73%
Caitong Securities Asset Management Co., Ltd.as of 30 Jun 20253.00m0.52%
Huashang Fund Management Co., Ltd.as of 30 Jun 20252.62m0.45%
Zhong Ou Asset Management Co., Ltdas of 30 Jun 20252.30m0.40%
GF Fund Management Co., Ltd.as of 30 Jun 20252.12m0.37%
More ▼
Data from 30 Jun 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.